These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 2976867

  • 1. [Pre-Sézary erythroderma developing into Sézary syndrome: apropos of 2 observations].
    Soria C, Ledo E, Sendagorta E, Ledo A, Rocamora A.
    Med Cutan Ibero Lat Am; 1988; 16(5):403-6. PubMed ID: 2976867
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
    el-Azhary RA, Bouwhuis SA.
    Int J Dermatol; 2005 Jan; 44(1):25-8. PubMed ID: 15663654
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sézary cell count in exfoliative dermatitis.
    Duangurai K, Piamphongsant T, Himmungnan T.
    Int J Dermatol; 1988 May; 27(4):248-52. PubMed ID: 2968960
    [Abstract] [Full Text] [Related]

  • 6. Acute hyperkeratotic and desquamative reaction in a patient with Sézary syndrome treated with bexarotene.
    Bagazgoitia L, Pérez-Carmona L, Ríos L, Muñoz E, Harto A, Jaén P.
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):389-90. PubMed ID: 18269619
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The Sézary syndrome--an erythrodermic T-cell-lymphoma].
    Haustein UF, Gast W, Schippel K, Schippel G, Rytter M.
    Z Gesamte Inn Med; 1979 Jan 15; 34(2):72-8. PubMed ID: 154782
    [Abstract] [Full Text] [Related]

  • 9. Sézary syndrome without erythroderma.
    Henn A, Michel L, Fite C, Deschamps L, Ortonne N, Ingen-Housz-Oro S, Marinho E, Beylot-Barry M, Bagot M, Laroche L, Crickx B, Maubec E.
    J Am Acad Dermatol; 2015 Jun 15; 72(6):1003-9.e1. PubMed ID: 25981000
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
    Bouwhuis SA, el-Azhary RA, McEvoy MT, Gibson LE, Habermann TM, Witzig TE, Pittelkow MR.
    Int J Dermatol; 2002 Jun 15; 41(6):352-6. PubMed ID: 12100691
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Atopic dermatitis-like pre-Sézary syndrome: role of immunosuppression.
    Sokołowska-Wojdyło M, Barańska-Rybak W, Cegielska A, Trzeciak M, Lugowska-Umer H, Gniadecki R.
    Acta Derm Venereol; 2011 Sep 15; 91(5):574-7. PubMed ID: 21681350
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sezary syndrome: diagnosis and management.
    Ogilvie C, Jackson R, Leach M, McKay P.
    J R Coll Physicians Edinb; 2012 Sep 15; 42(4):317-21. PubMed ID: 23240118
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.